Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination

Pediatric Infectious Disease Journal

Volumn 19, Issue 5, 2000, Pages 417-423

  Rennels, Margaret B ^a,g   Englund, Janet A ^b   Bernstein, David I ^c   Losonsky, Genevieve A ^a   Anderson, Edwin L ^d   Pichichero, Michael E ^e   Munoz, Flor M ^b   Wolff, Mark C ^f  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d SAINT LOUIS UNIVERSITY   (United States)

^e UNIVERSITY OF ROCHESTER   (United States)

^f EMMES CORPORATION   (United States)

^g NONE   (United States)

Author keywords

Haemophilus; Pertussis; Vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INACTIVATED VACCINE; ORAL POLIOMYELITIS VACCINE; PHOSPHATE; RIBITOL; RIBOSE;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VACCINATION;

EID: 0034111435     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200005000-00006     Document Type: Article

References (32)

1. Advisory Committee on Immunization Practices. Revised recommendations for routine poliovirus vaccination. MMWR 1999;48:590.
2. Meade BD, Deforest A, Edwards KM, et al. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics 1995;96:S570-5.
3. DiJohn D, Wasserman S, Torres JR, et al. Effect of priming with carrier on response to conjugate vaccine. Lancet 1989; 2:1415-8.
4. Gupta RK, Griffin P, Su J, Rivera R, Thompson C, Siber G. Diphtheria antitoxin levels in US blood and plasma donors. J Infect Dis 1996;173:1493-7.
5. King GE, Hadler SC. Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious. Pediatr Infect Dis J 1994;13:394-407.
6. Halperin SA, Langley JM, Eastwood BJ. Effect of inactivated poliovirus vaccine on the antibody response to Bordetella pertussis antigens when combined with diphtheria-pertussis-tetanus vaccine. Clin Infect Dis 1996;22:59-62.
7. Lagos R, Kotloff K, Hoffenbach A, et al. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four-, and six-month-old Chilean infants. Pediatr Infect Dis J 1998;17:294-304.
8. Greenberg DP, Vadheim CM, Partridge S, et al. Immunogenicity of Haemophilus influenzae type b tetanus toxoid conjugate vaccine in young infants. J Infect Dis 1994;70:76-81.
9. Fritzell B, Plotkin S. Efficacy and safety of a Haemophilus influenzae type b capsular protein conjugate vaccine. J Pediatr 1992;121:355-62.
10. Santosham M, Hill J, Wolff M, Reid R, Lukacs L, Ahonkhai V. Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population. Pediatr Infect Dis J 1991;10:113-7.
11. Black SB, Shinefield HR, Lampert D, et al. Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. Pediatr Infect Dis J 1991;10:92-6.
12. Granoff DM, Anderson EL, Osterholm MT, et al. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J Pediatr 1992;121:187-94.
13. Bulkow LR, Wainwright RB, Letson GW, Chang SJ, Ward JI. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants. Pediatr Infect Dis J 1993;12:484-92.
14. Miller MA, Meschievitz CK, Ballanco GA, Daum RS. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. Pediatrics 1995;95: 522-7.
15. Ahonkhai VI, Lukacs LJ, Ellis RW, et al. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation. Pediatrics 1990; 85:S676-81.
16. Decker MD, Edwards KM, Bradley R, Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr 1992;120:184-9.
17. Eskola J, Ölander R-M, Hovi T, Litmanen L, Peltola S, Käyhty H. Randomized trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. Lancet 1996;348:1688-92.
18. Halsey NA, Blatter M, Bader M, et al. Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four-and six-month-old infants with combination Haemophilus influenzae type b/hepatitis B vaccine. Pediatr Infect Dis J 1997;16:675-9.
19. Anderson EL, Decker MD, Englund JA, et al. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants. JAMA 1995;273:849-53.
20. Pichichero ME, Latiolais T, Bernstein DI, et al. Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four-and six-month-old infants. Pediatr Infect Dis J 1997;16:863-70.
21. Pichichero ME, Passador S. Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis b vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants. Clin Infect Dis 1997;25:1378-84.
22. Halperin SA, King J, Law B, Mills E, Willems P. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses. Clin Infect Dis 1999;28:995-1001.
23. Insel RA. Potential alterations in immunogenicity by combining or simultaneously administering vaccine components. Ann NY Acad Sci 1995;754:35-47.
24. Dagan R, Eskola J, Leclerc C, Leroy O. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun 1998; 66:2093-8.
25. Mills E, Gold R, Thipphawong J, Barreto L, et al. Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus b conjugate vaccine administered to infants at two, four and six months of age. Vaccine 1997;16:576-85.
26. Lee CY, Thipphawong J, Huang LM, et al. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants. Pediatrics 1999;103:25-30.
27. Centers for Disease Control and Prevention. FDA approval of a Haemophilus b vaccine combined by reconstitution with an acellular pertussis vaccine. MMWR 1996;45:993-5.
28. Faden H, Modlin JF, Thoms ML, McBean AM, Ferdon MB, Ogra PL. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent polio-virus vaccines in childhood: systemic and local immune responses. J Infect Dis 1990;162:1291-7.
29. Modlin JF, Halsey NA, Thoms ML, Meschievitz CK, Patriarca PA. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. J Infect Dis 1997;175(Suppl 1):S228-34.
30. Zeep F, Schmitt HJ, Kaufhold A, et al. Evidence for induction of polysaccharide specific B-cell memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. Eur J Pediatr 1997;156:18-24.
31. Bell F, Heath P, Shackley F, et al. Effect of combination with an acellular pertussis, diphtheria, tetanus vaccine on antibody response to Hib vaccine (PRP-T). Vaccine 1998:16637-42.
32. Pichichero ME, Voloshen T, Passador S. Kinetics of booster responses to Haemophilus influenza type b conjugate after combined diphtheria-tetanus-acellular pertussis Haemophilus influenzae type b vaccination in infants. Pediatr Infect Dis J 1999;18:1106-8.